Evidence map›Paper›PMID 30014822›Full record

ArticleThe American journal of tropical medicine and hygiene2018

Melioidosis is in the Americas: A Call to Action for Diagnosing and Treating the Disease.

Alfredo G Torres, Franco E Montufar, Jay E Gee, Alex R Hoffmaster, Mindy G Elrod, Carolina Duarte-Valderrama, Monica G Huertas, David D Blaney

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Antimicrobial Susceptibility of Western Hemisphere Isolates ofMicrobial drug resistance (Larchmont, N.Y.) · 2021
    Article
  4. Article
  5. Article
  6. Review
  7. TheFrontiers in microbiology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alfredo G TorresDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas.
Franco E MontufarClinical Pneumology, León XIII Clinic of Antioquia University, Infectology Post-Degree of Pontificia Bolivariana University, Medellin, Colombia.
Jay E GeeCenters for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia.
Alex R HoffmasterCenters for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia.
Mindy G ElrodCenters for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia.
Carolina Duarte-ValderramaNational Institute of Health, Microbiology Group, Direction in Public Health Networks, Bogota, Colombia.
Monica G HuertasUniversity el Bosque, Bogota, Colombia.
David D BlaneyCenters for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia.

Funding

Glycoconjugate Nanoparticle Vaccines Against Burkholderia InfectionsR01AI126601 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI TORRES, ALFREDO G · 2016 to 2020
$2.1M
NIAID NIH HHS R01 AI126601
6 · The paper itself

Abstract

Melioidosis, a disease caused by the pathogen

Indexed as

AmericasAnti-Bacterial AgentsBacteremiaBurkholderia pseudomalleiColombiaHumansMelioidosisTravelUnited StatesAnti-Bacterial Agents

Identifiers

PMID30014822
PMCPMC6169178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.